Home Cart Sign in  
Chemical Structure| 1434639-57-2 Chemical Structure| 1434639-57-2

Structure of ND-646
CAS No.: 1434639-57-2

Chemical Structure| 1434639-57-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ND-646 is an allosteric inhibitor of the ACC enzymes ACC1 and ACC2 that prevents ACC subunit dimerization-to suppress fatty acid synthesis in vitro and in vivo. Chronic ND-646 treatment of xenograft and genetically engineered mouse models of NSCLC inhibited tumor growth.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ND-646

CAS No. :1434639-57-2
Formula : C28H32N4O7S
M.W : 568.64
SMILES Code : O=C(N)C(C)(C)N(C(N(C[C@@H](C1=CC=CC=C1OC)OC2CCOCC2)C3=C4C(C)=C(C5=NC=CO5)S3)=O)C4=O
MDL No. :MFCD30802583
InChI Key :HSRWXLIYNCKHRZ-FQEVSTJZSA-N
Pubchem ID :71570560

Safety of ND-646

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of ND-646

ferroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
OLN93 cells 5 nM 12 h ND-646 reduced lipid ROS accumulation in OLN93 cells and protected them from ferroptosis. PMC10755589
A549 500 nM 24 h ND-646 significantly inhibited the proliferation and viability of A549 cells and induced apoptosis and ER stress. PMC5053891
H157 500 nM 24 h ND-646 significantly inhibited the proliferation and viability of H157 cells and induced apoptosis and ER stress. PMC5053891
melanoma cells 4 nM 48 h ND-646 significantly induced cell death in melanoma cells treated with either media alone or young fibroblast CM, whereas cell death was significantly decreased in the presence of aged fibroblast CM, suggesting that melanoma cells in aged media do not rely solely on fatty acid synthesis as the source of endogenous lipids. PMC7483379
KKU-055 0, 0.1, 0.5, 1.0 µM 24 h To evaluate the effects of ND-646 on CCA cell proliferation and migration, results showed that ND-646 inhibited colony formation and cell migration in a dose-dependent manner. PMC11432552
KKU-213A 0, 0.1, 0.5, 1.0 µM 24 h To evaluate the effects of ND-646 on CCA cell proliferation and migration, results showed that ND-646 inhibited colony formation and cell migration in a dose-dependent manner. PMC11432552
MDA-MB-231 10 μM 4 d To evaluate the inhibitory effects of ND-646 on the growth of MDA-MB-231 cells, the results showed that ND-646 had a marginal inhibitory effect on cell growth. PMC9757841
HeLa 10 μM 4 d To evaluate the inhibitory effects of ND-646 on the growth of HeLa cells, the results showed that ND-646 had a marginal inhibitory effect on cell growth. PMC9757841
HCT116 10 μM 4 d To evaluate the inhibitory effects of ND-646 on the growth of HCT116 cells, the results showed that ND-646 had a marginal inhibitory effect on cell growth. PMC9757841
HCT-8 10 μM 4 d To evaluate the inhibitory effects of ND-646 on the growth of HCT-8 cells, the results showed that ND-646 had a marginal inhibitory effect on cell growth. PMC9757841

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice intracerebral hemorrhage model intracerebroventricular injection 1 μM,1 μL 0, 2, 4, 6 days ND-646 significantly reduced OPC cell death in the intracerebral hemorrhage model mice and improved cognitive function. PMC10755589
Mice Neonatal mice (P7) Intraperitoneal injection 20 mg/kg Single injection, 15 minutes exposure To assess whether ND-646 could attenuate VA-induced β-HB depletion, results showed that ND-646 significantly attenuated the drop in β-HB caused by isoflurane exposure PMC8291971
Mice NSCLC xenograft model Oral 25 mg/kg, 50 mg/kg, 100 mg/kg Once or twice daily for 31 days ND-646 significantly inhibited tumor growth in NSCLC xenograft models and reduced fatty acid synthesis in tumors. PMC5053891
Balb/c Rag-2/Jak3 double-deficient mice CCA xenograft model Intraperitoneal injection 100 mg/kg 5 days/week for 2 weeks To evaluate the effects of SAHA on CCA growth, results showed that SAHA suppressed CCA growth, as demonstrated by reduced tumor size, volume, and weight. PMC11432552
Mice Nude mice xenograft model Oral 25 mg/kg or 50 mg/kg Once daily for 21 days To evaluate the inhibitory effects of ND-646 on tumor growth, the results showed that ND-646 significantly inhibited tumor growth. PMC9757841

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.79mL

1.76mL

0.88mL

17.59mL

3.52mL

1.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories